Sources familiar with the matter indicated on Monday (August 24) that Shell's U.S. chemicals business has received multiple non-binding indications of interest, with potential suitors including Exxon Mobil, LyondellBasell, Apollo Global Management, and the chemicals arm of Kuwait Petroleum Corporation. The combined asset package could potentially fetch up to $8 billion. The bids cover both a full-package sale and piecemeal divestitures, though a transaction is not guaranteed to materialize. Shell declined to comment on the sale speculation, and most of the named bidders have not responded to requests for comment.

The Shell Polymers facility in Monaca, Pennsylvania, which commenced operations in 2022 with an investment of approximately $14 billion, has been included by sources in the proposed sale of U.S. chemical assets.

Bids are indications, not completed deals

According to the sources, interested parties submitted non-binding indicative offers in July. The $8 billion figure represents the upper limit of what this batch of U.S. assets "could potentially command" in aggregate, not a signed consideration or a locked-in bid from a single buyer. Some parties have bid for the entire package, while others have expressed interest in only a portion of it. The sources made clear there is no guarantee the process will reach a signed agreement.

Shell has not issued an official confirmation regarding these figures. The English-language report relaying the news stated that Shell declined to comment, Exxon Mobil and Apollo also declined, and LyondellBasell and Kuwait Petroleum Corporation did not respond to comment requests. As of now, there has been no joint announcement from buyer and seller, nor any deal documents filed with regulatory authorities.

The European chemicals business was mentioned separately: Shell is also engaging with advisers to solicit bids externally, with sources noting the European portion carries a significantly lower valuation. The European inquiry is a separate matter from the $8 billion U.S. deal.

Four plants and the Monaca ledger

The U.S. chemicals operations have been described as spanning four plant sites distributed across Louisiana, Texas, and Pennsylvania, producing materials used in plastics, detergents, and pharmaceutical intermediates. Among the listed sites, the large Monaca polymers facility in Pennsylvania stands out: commissioned in 2022, Shell's cumulative capital expenditure there is approximately $14 billion, with a maximum annual production capacity of roughly 1.6 million tonnes of polymers.

If the entire U.S. package were to sell for only around $8 billion, the gap compared to the approximately $14 billion already invested in the Monaca plant alone represents what sources describe as a "significant discount." The discount is measured against cumulative capital invested, not the book value or replacement cost of the four plants—neither of which was provided in this report.

Chief Executive Wael Sawan stated last year that Shell holds approximately $45 billion in capital "underperforming expectations," spread across both chemicals and renewables. In March of last year, the company stated it does not consider itself the "natural owner" of its chemicals portfolio and aims to reduce its exposure by 2030. In February of this year, he reiterated that the company would remain patient and did not want to sell at the bottom of the cycle. These are publicly stated strategic positions, not new commentary regarding this week's solicitation.

Before Middle East hostilities pushed up oil prices and chemicals margins, the chemicals division was loss-making for most of the recent period. In the second quarter, Shell posted adjusted earnings of $9.84 billion, up from $4.26 billion in the same period last year, marking its strongest quarter since Q2 2022; the drivers were cited as oil prices, trading, and refining throughput, with improved chemicals margins as well. The earnings recovery and whether the U.S. plants are sold for $8 billion are two separate matters.

Who are the buyers, and which front is being sold?

Among the four named interested parties, Exxon Mobil and LyondellBasell are established U.S. chemical operators. Apollo is a private equity firm. The chemicals division of Kuwait Petroleum Corporation is the chemicals arm within a national oil company structure. The report did not specify each party's individual bid, whether they are forming a consortium, or if any are seeking only the Monaca facility.

In the same period, Chevron, ADNOC, and Saudi Aramco continue to expand or evaluate chemical investments, with the logic of extending the crude value chain toward plastics and chemicals. Road fuel demand is expected to decline with electric vehicle adoption, while chemicals demand is projected to keep growing. Shell is taking a different path: marking underperforming chemical assets for sale and redeploying capital back into upstream and trading.

Recent completed divestitures include: the sale of European onshore renewables operations to TotalEnergies; and the sale of a 35% stake in Cyprus offshore Block 12 to Hungary's MOL for $720 million. The U.S. chemicals deal remains at the non-binding offer stage.

What remains undetermined is the buyer, the consideration, whether it will be a full package or piecemeal sale, and whether a deal will be reached at all. What is already on paper is only the batch of non-binding indications from July, along with the company's prior public stance of "reducing chemical exposure, but not wanting to sell at the bottom of the cycle."